Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK

Biochemical and Biophysical Research Communications

Volumn 398, Issue 2, 2010, Pages 178-183

  Zygmunt, Katarzyna ^a   Faubert, Brandon ^a   MacNeil, Jordan ^a   Tsiani, Evangelia ^a  

^a BROCK UNIVERSITY   (Canada)

Author keywords

Akt; AMPK; Glucose uptake; Myotubes; Naringenin; SIRT1

Indexed keywords

ENZYME INHIBITOR; EX 527; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; NARINGENIN; NICOTINAMIDE; PROTEIN KINASE B; SIRTUIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE SILENCING; GLUCOSE TRANSPORT; INSULIN RESPONSE; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; CITRUS PARADISI; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FLAVANONES; FLAVONOIDS; GLUCOSE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN KINASES; RATS; RNA, SMALL INTERFERING; SIRTUIN 1;

CITRUS; CITRUS X PARADISI;

EID: 77955052130     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.048     Document Type: Article

References (34)

1. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799.
2. Bjornholm M., Zierath J.R. Insulin signal transduction in human skeletal muscle: identifying the defects in type II diabetes. Biochem. Soc. Trans. 2005, 33:354-357.
3. Towler M.C., Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 2007, 100:328-341.
4. Hardie D.G. AMP-activated protein kinase: a key system mediating metabolic responses to exercise. Med. Sci. Sports Exerc. 2004, 36:28-34.
5. Zou M.H., Kirkpatrick S.S., Davis B.J., Nelson J.S., Wiles W.G., Schlattner U., Neumann D., Brownlee M., Freeman M.B., Goldman M.H. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo role of mitochondrial reactive nitrogen species. J. Biol. Chem. 2004, 279:43940-43951.
6. Konrad D., Rudich A., Bilan P.J., Patel N., Richardson C., Witters L.A., Klip A. Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells. Diabetologia 2005, 48:954-966.
7. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
8. Breen D.M., Sanli T., Giacca A., Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem. Biophys. Res. Commun. 2008, 374:117-122.
9. van Acker F.A., Schouten O., Haenen G.R., van der Vijgh W.J., Bast A. Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett. 2000, 473:145-148.
10. Guthrie N., Carroll K.K. Inhibition of mammary cancer by citrus flavonoids. Adv. Exp. Med. Biol. 1998, 439:227-236.
11. Mulvihill E.E., Huff M.W. Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can. J. Cardiol. 2010, 26(Suppl. A):17A-21A.
12. Borradaile N.M., de Dreu L.E., Huff M.W. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes 2003, 52:2554-2561.
13. Mulvihill E.E., Allister E.M., Sutherland B.G., Telford D.E., Sawyez C.G., Edwards J.Y., Markle J.M., Hegele R.A., Huff M.W. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 2009, 58:2198-2210.
14. Choi J.S., Yokozawa T., Oura H. Improvement of hyperglycemia, hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems, its main component. Prunin Planta Med. 1991, 57:208-211.
15. Ortiz-Andrade R.R., Sanchez-Salgado J.C., Navarrete-Vazquez G., Webster S.P., Binnie M., Garcia-Jimenez S., Leon-Rivera I., Cigarroa-Vazquez P., Villalobos-Molina R., Estrada-Soto S. Antidiabetic, toxicological evaluations of naringenin in normoglycaemic, NIDDM rat models, its implications on extra-pancreatic glucose regulation. Diabetes Obes. Metab. 2008, 10:1097-1104.
16. Kannappan S., Anuradha C.V. Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome. Eur. J. Nutr. 2010, 49:101-109.
17. Sanchez-Salgado J.C., Ortiz-Andrade R.R., Aguirre-Crespo F., Vergara-Galicia J., Leon-Rivera I., Montes S., Villalobos-Molina R., Estrada-Soto S. Hypoglycemic, vasorelaxant and hepatoprotective effects of Cochlospermum vitifolium (willd.) sprengel: a potential agent for the treatment of metabolic syndrome. J. Ethnopharmacol. 2007, 109:400-405.
18. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79:727-747.
19. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
20. Hou X., Xu S., Maitland-Toolan K.A., Sato K., Jiang B., Ido Y., Lan F., Walsh K., Wierzbicki M., Verbeuren T.J., Cohen R.A., Zang M. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 2008, 283:20015-20026.
21. Lan F., Cacicedo J.M., Ruderman N., Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 2008, 283:27628-27635.
22. Mitsumoto Y., Burdett E., Grant A., Klip A. Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells. Biochem. Biophys. Res. Commun. 1991, 175:652-659.
23. Erlund I., Meririnne E., Alfthan G., Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J. Nutr. 2001, 131:235-241.
24. Park J.B. Flavonoids are potential inhibitors of glucose uptake in U937 cells. Biochem. Biophys. Res. Commun. 1999, 260:568-574.
25. Harmon A.W., Patel Y.M. Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res. Treat. 2004, 85:103-110.
26. Harmon A.W., Patel Y.M. Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2003, 305:229-234.
27. +-glucose cotransporter by naringenin. Int. J. Biochem. Cell Biol. 2006, 38:985-995.
28. Lim S.L., Soh K.P., Kuppusamy U.R. Effects of naringenin on lipogenesis, lipolysis and glucose uptake in rat adipocyte primary culture: a natural antidiabetic agent. Internet J. Altern. Med. 2008, 5:1-9.
29. Purintrapiban J., Suttajit M., Forsberg N.E. Differential activation of glucose transport in cultured muscle cells by polyphenolic compounds from Canna indica L. root. Biol. Pharm. Bull. 2006, 29:1995-1998.
30. Park C.E., Kim M.J., Lee J.H., Min B.I., Bae H., Choe W., Kim S.S., Ha J. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp. Mol. Med. 2007, 39:222-229.
31. Musi N., Goodyear L.J. AMP-activated protein kinase and muscle glucose uptake. Acta Physiol. Scand. 2003, 178:337-345.
32. Um J.H., Park S.J., Kang H., Yang S., Foretz M., McBurney M.W., Kim M.K., Viollet B., Chung J.H. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59:554-563.
33. Fullerton M.D., Steinberg G.R. SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol. Diabetes 2010, 59:551-553.
34. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.